Stockreport

Minerva Neurosciences Presents Data from its Open-label Safety Trial Evaluating Roluperidone Co-administered with Olanzapine at SIRS 2026 [Yahoo! Finance]

Minerva Neurosciences, Inc  (NERV) 
Last minerva neurosciences, inc earnings: 3/9 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.minervaneurosciences.com/investor-relations
PDF The Company continues to advance the program, with the confirmatory Phase 3 trial now enrolling and topline data anticipated in the second half of 2027 BURLINGTON, Ma [Read more]